The role of the Shc phosphotyrosine interaction phosphotyrosine binding domain and tyrosine phosphorylation sites in polyoma middle T antigen-mediated cell transformation

被引:31
作者
Blaikie, PA
Fournier, E
Dilworth, SM
Birnbaum, D
Borg, JP
Margolis, B
机构
[1] UNIV MICHIGAN, SCH MED, DEPT INTERNAL MED & BIOL CHEM, ANN ARBOR, MI 48109 USA
[2] NYU, MED CTR, DEPT PHARMACOL, NEW YORK, NY 10016 USA
[3] ROYAL POSTGRAD MED SCH, DEPT METAB MED, LONDON W12 0NN, ENGLAND
[4] INSERM, U1119, ONCOL MOL LAB, F-13009 MARSEILLE, FRANCE
关键词
D O I
10.1074/jbc.272.33.20671
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The phosphotyrosine Interaction (PI)/phosphotyrosine binding (PTB) domain of She binds specific tyrosine-phosphorylated motifs found on activated growth factor receptors and proteins such as polyoma virus middle T antigen (MT), Phenylalanine 198 (Phe(198)) has been identified as a crucial residue involved in the interaction of the She PI/PTB with phosphopeptides. In MH3T3 cells expressing MT, p52 She carrying the F198V mutation is weakly phosphorylated and does not bind MT or Grb2. Overexpression of the PI/PTB domain alone as She amino acids 1-238 acted in a dominant interfering fashion blocking MT-induced transformation, However, expression of a slightly longer construct, She 1-260, which encompasses Tyr(239)/Tyr(240), a novel She tyrosine phosphorylation site, did not block transformation, This was found to be due to the ability of She 1-260 to become tyrosine-phosphorylated and bind Grb2. Furthermore, full-length She in which Tyr(239)/Tyr(240) had been mutated to phenylalanine did not become tyrosine-phosphorylated or bind Grb2 but did inhibit colony formation in soft agar, Conversely, p52 She carrying a mutation in the other tyrosine phosphorylation site, Tyr(317), became heavily tyrosine-phosphorylated, bound Grb2, and gave rise to colonies in soft agar.
引用
收藏
页码:20671 / 20677
页数:7
相关论文
共 52 条
[1]   INTERNAL INITIATION OF TRANSLATION IN RETROVIRAL VECTORS CARRYING PICORNAVIRUS-5' NONTRANSLATED REGIONS [J].
ADAM, MA ;
RAMESH, N ;
MILLER, AD ;
OSBORNE, WRA .
JOURNAL OF VIROLOGY, 1991, 65 (09) :4985-4990
[2]  
Ausubel F.M., 1992, CURRENT PROTOCOLS MO
[3]  
BATZER AG, 1995, MOL CELL BIOL, V15, P4403
[4]   HIERARCHY OF BINDING-SITES FOR GRB2 AND SHC ON THE EPIDERMAL GROWTH-FACTOR RECEPTOR [J].
BATZER, AG ;
ROTIN, D ;
URENA, JM ;
SKOLNIK, EY ;
SCHLESSINGER, J .
MOLECULAR AND CELLULAR BIOLOGY, 1994, 14 (08) :5192-5201
[5]  
BLAIKIE P, 1994, J BIOL CHEM, V269, P32031
[6]   Not all Shc's roads lead to Ras [J].
Bonfini, L ;
Migliaccio, E ;
Pelicci, G ;
Lanfrancone, L ;
Pelicci, P .
TRENDS IN BIOCHEMICAL SCIENCES, 1996, 21 (07) :257-261
[7]   A PHOSPHOTYROSINE INTERACTION DOMAIN [J].
BORK, P ;
MARGOLIS, B .
CELL, 1995, 80 (05) :693-694
[8]   POLYOMA MIDDLE TUMOR-ANTIGEN INTERACTS WITH SHC PROTEIN VIA THE NPTY (ASN-PRO-THR-TYR) MOTIF IN MIDDLE TUMOR-ANTIGEN [J].
CAMPBELL, KS ;
OGRIS, E ;
BURKE, B ;
SU, W ;
AUGER, KR ;
DRUKER, BJ ;
SCHAFFHAUSEN, BS ;
ROBERTS, TM ;
PALLAS, DC .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (14) :6344-6348
[9]   MUTATIONS AROUND THE NG59 LESION INDICATE AN ACTIVE ASSOCIATION OF POLYOMA-VIRUS MIDDLE-T ANTIGEN WITH PP60C-SRC IS REQUIRED FOR CELL-TRANSFORMATION [J].
CHENG, SH ;
MARKLAND, W ;
MARKHAM, AF ;
SMITH, AE .
EMBO JOURNAL, 1986, 5 (02) :325-334
[10]  
COURTNEIDGE SA, 1986, CANCER SURV, V5, P173